tiprankstipranks
Advertisement
Advertisement
iRadimed reports Q1 adjusted EPS 49c, consensus 44c
PremiumThe FlyiRadimed reports Q1 adjusted EPS 49c, consensus 44c
4M ago
iRadimed sees Q2 EPS 44c-48c, consensus 47c
Premium
The Fly
iRadimed sees Q2 EPS 44c-48c, consensus 47c
4M ago
iRadimed backs FY26 EPS view $2.06-$2.21, consensus $2.08
Premium
The Fly
iRadimed backs FY26 EPS view $2.06-$2.21, consensus $2.08
4M ago
Iradimed Corp Eyes 2026 Surge After Strong Quarter
PremiumCompany AnnouncementsIradimed Corp Eyes 2026 Surge After Strong Quarter
7M ago
iRadimed price target raised to $120 from $98 at Roth Capital
Premium
The Fly
iRadimed price target raised to $120 from $98 at Roth Capital
7M ago
Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback
Premium
The Fly
Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback
7M ago
iRadimed board approves special cash dividend of 50c per share
PremiumThe FlyiRadimed board approves special cash dividend of 50c per share
9M ago
Iradimed Corp’s Earnings Call Highlights Record Growth and Optimism
Premium
Company Announcements
Iradimed Corp’s Earnings Call Highlights Record Growth and Optimism
10M ago
iRadimed price target raised to $98 from $90 at Roth Capital
Premium
The Fly
iRadimed price target raised to $98 from $90 at Roth Capital
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100